Jenny Byrne
Overview
Explore the profile of Jenny Byrne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liebers N, Boumendil A, Finel H, Edelmann D, Kobbe G, Baermann B, et al.
Blood Cancer Discov
. 2025 Feb;
PMID: 39913291
Brexucabtagene autoleucel (brexu-cel) and allogeneic hematopoietic cell transplantation (alloHCT) are effective treatments for relapsed or refractory mantle cell lymphoma (r/r MCL), but the optimal choice remains unclear. We conducted an...
2.
Baron F, Labopin M, Versluis J, Vydra J, von dem Borne P, Nicholson E, et al.
Am J Hematol
. 2024 Aug;
99(12):2296-2305.
PMID: 39215605
The best donor option for acute myeloid leukemia (AML) patients lacking an HLA-matched donor has remained intensively debated. We herein report the results of a large retrospective registry study comparing...
3.
Onida F, Gras L, Ge J, Koster L, Hamladji R, Byrne J, et al.
Br J Haematol
. 2024 Apr;
204(6):2365-2377.
PMID: 38577874
Allogeneic haematopoietic cell transplantation (allo-HCT) remains an option for tyrosine kinase inhibitor-resistant chronic myeloid leukaemia (CML) in first chronic phase (CP1) and high-risk patients with advanced disease phases. In this...
4.
Guieze R, Eikema D, Koster L, Schetelig J, Sengeloev H, Passweg J, et al.
Bone Marrow Transplant
. 2024 Mar;
59(7):950-956.
PMID: 38503942
Management of Richter transformation (RT) is particularly challenging, with survival estimates <1 year. We report on outcomes of 66 RT patients undergoing allogeneic-HCT (allo-HCT) between 2008 and 2018 registered with...
5.
Pietka G, De Lord C, Matthias G, Cheung B, Atwal S, Furtado M, et al.
Br J Haematol
. 2024 Mar;
204(4):1325-1334.
PMID: 38462984
We report on a study of next-generation sequencing in 257 patients undergoing investigations for cytopenias. We sequenced bone marrow aspirates using a target enrichment panel comprising 82 genes and used...
6.
Orti G, Gras L, Koster L, Kulagin A, Byrne J, Apperley J, et al.
Transplant Cell Ther
. 2023 Oct;
30(1):93.e1-93.e12.
PMID: 37783337
Outcomes following allogeneic hematopoietic cell transplantation (allo-HCT) for chronic myeloid leukemia (CML) with post-transplantation cyclophosphamide (PTCy) using an unrelated donor (UD) or a mismatched related donor (MMRD) remain unknown. We...
7.
Pinana J, Tridello G, Xhaard A, Wendel L, Montoro J, Vazquez L, et al.
J Infect Dis
. 2023 Jul;
229(1):83-94.
PMID: 37440459
Background: Human metapneumovirus (hMPV) epidemiology, clinical characteristics and risk factors for poor outcome after allogeneic stem cell transplantation (allo-HCT) remain a poorly investigated area. Methods: This retrospective multicenter cohort study...
8.
Loke J, Upasani V, Gaskell C, Fox S, Fletcher R, Thomas C, et al.
Br J Haematol
. 2023 Jun;
202(3):498-503.
PMID: 37303189
Limited data exist on COVID-19 vaccination efficacy in patients with acute myeloid leukemia and myelodysplasia with excess blasts (AML/MDS-EB2). We report results from a prospective study, PACE (Patients with AML...
9.
Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, et al.
Bone Marrow Transplant
. 2023 Apr;
58(7):791-800.
PMID: 37045942
We compared transplants (HSCT) from matched related siblings (MSD) with those from matched 10/10 and mismatched 9/10 unrelated (UD) and T-replete haploidentical (Haplo) donors in acute myeloid leukemia (AML) in...
10.
Fernando F, Innes A, Claudiani S, Pryce A, Hayden C, Byrne J, et al.
Bone Marrow Transplant
. 2023 Apr;
58(7):826-828.
PMID: 37015970
No abstract available.